Navigation Links
OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
Date:9/22/2008

First, Flexible CO2 Laser Scalpel Provides Surgeons with No-Touch Surgical Tool For Precision Brain and Spine Surgery

CAMBRIDGE, Mass., Sept. 22 /PRNewswire/ -- OmniGuide, Inc., announced today the introduction of the new BeamPath NEURO(TM), the first flexible CO2 laser scalpel for neurosurgery. The BeamPath NEURO fiber provides surgeons with a precise, no-touch microsurgical tool for various central nervous system (CNS) procedures, including intracranial tumor surgeries, spine tumor surgeries and transnasal pituitary surgeries. BeamPath NEURO is designed for operating near critical structures, for accessing difficult to reach regions of the brain and for minimizing thermal injury to adjacent healthy tissue of the brain or spine.

The clinical benefits of CO2 lasers for neurosurgery were recognized 30 years ago. However, prior to BeamPath, CO2 lasers could only be delivered through a large articulated arm system and were limited to "line-of-sight" procedures. As a result, for the past twenty years, CO2 lasers have rarely been used in neurosurgery. With the introduction of the BeamPath NEURO flexible CO2 laser, neurosurgeons now have the ability to perform precise dissection, cutting, debulking, and microvascular coagulation using a hand-held, no-touch instrument.

"Neurosurgeons have long realized the benefits of CO2 lasers for microsurgery, but the traditional means of delivering the laser were too rigid and unwieldy for microsurgery, limiting lasers' use in our specialty," said Robert F. Spetzler, M.D., F.A.C.S., Director, Barrow Neurological Institute, J.N. Harbor Chairman of Neurological Surgery in Phoenix, Ariz. "A flexible CO2 laser is ideal for removing small tumors that are in close proximity to critical structures, including very sensitive areas of the brain and spinal cord, as well as for tumors in deep holes, when the most precise, no-touch surgical tool is essential."

BeamPath NEURO fibers empower surgeons to perform delicate cutting and coagulation with minimal thermal tissue damage and ultimate maneuverability. With one surgical tool, BeamPath NEURO enables:

-- Precise dissection--enables pin-point accuracy while separating adherent

tumor from critical structures.

-- Cutting--allows for efficient and precise removal of tumor and tumor

remnants.

-- Debulking--shrinks tumor mass in a layer-by-layer fashion.

-- Microvascular Coagulation--enables the surgeon to operate on appropriate

tumors within a clean field.

-- A surgeon-controlled, no-touch tool--reduces tissue retraction and

manipulation leading to limited post-op edema and possibly quicker

recovery.

"OmniGuide is experiencing strong demand for our precision surgical systems across a multiplicity of clinical verticals including head and neck cancer, otology and airway surgery," said Yoel Fink, OmniGuide co-founder and CEO. "The BeamPath NEURO represents an important step towards capturing value by developing scalpels that target specific clinical indications and disease states. We are excited to expand into the neurosurgery market where we are satisfying an unmet need for a precise, no-touch, minimally invasive optical scalpel."

The BeamPath NEURO-L Fiber and four BeamPath NEURO hand pieces are now available through OmniGuide by calling 1-888-OMNI-GUIDE.

About OmniGuide, Inc.

OmniGuide, Inc., is the worldwide leader in precision optical scalpels for minimally invasive surgery. OmniGuide CO2 laser fiber products are clinically targeted disposable optical scalpels optimized for specific surgical procedures. The Company has recently introduced a line of fiber-enabled, portable, low-cost CO2 laser systems for use in operating rooms and surgical suites. The Company designs and manufactures its fiber products in Cambridge, Mass. based on multi-material photonic bandgap fiber technology exclusively licensed from MIT. The company distributes its products in the U.S. and Europe. OmniGuide is committed to developing products that improve and expand surgical treatment options, enhance clinical outcomes, and reduce treatment complexity and cost.

Since being cleared by the FDA in 2006, BeamPath fibers have been used in close to 5,000 surgical procedures for otology, laryngology, airway and head and neck procedures. OmniGuide has several leading-edge flexible laser fibers for use in both hospital and office settings; leading brands include the BeamPath(TM) ENT for laryngology, airway and head and neck procedures and BeamPath OTO for Otology procedures. Additional information about OmniGuide may be found at http://www.omni-guide.com.

Contacts: Dana Conti or Lori Stein

Schwartz Communications

(781) 684-0770

OmniGuide@schwartz-pr.com


'/>"/>
SOURCE OmniGuide, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
2. McGraw-Hill Higher Education Introduces New Introductory Level Biology Content
3. LUMEDX Introduces Advanced Multi-Modality, Multi-Vendor, Web-Enabled ECG Management Solution
4. LI-COR August 27th On-Line Webinar Introduces New Approach to Small Animal In Vivo Imaging
5. CriticalPoint(TM) Introduces Crosswalk Tool for Sterile Compounding Regulatory Requirements
6. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
7. Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
8. Nikon Instruments Introduces New Microscopes and Illumination Stand for Education and OEM Markets
9. Liko Introduces Two Additions to Its Stat Family of Low Friction Sheets
10. Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R)
11. Berkley Life Sciences Introduces LS Prime: A Revolutionary New Primary Liability Policy for the Life Science Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):